Craft

iBio

Stock Price

$2.8

2024-10-24

Market Capitalization

$25.6 M

2024-10-24

Revenue

$225 K

FY, 2024

iBio Summary

Company Summary

Overview
iBio is a biotechnology company and biologics contract development and manufacturing organization (CDMO). It develops products to treat fibrotic diseases, cancers, and infectious diseases. iBio's platforms and programs include CDMO services using its FastPharming technologies and glycaneering services; the development of therapeutics and vaccines, for which iBio conducts preclinical and clinical trials, and the production of proteins for research and further manufacturing use in 3D-bioprinting and other applications.
Type
Public
Status
Active
Founded
2008
HQ
Bryan, TX, US | view all locations
Website
http://ibioinc.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Martin B. Brenner

    Martin B. Brenner, Chief Scientific Officer

  • Gary Sender
  • Linda Armstrong
  • James T. Hill, Director

    Operating MetricsView all

    Patents Issued

    67

    FY, 2016

    Patents Pending

    19

    FY, 2016

    LocationsView all

    2 locations detected

    • Bryan, TX HQ

      United States

      8800 HSC Pkwy

    • San Diego, CA

      United States

      11750 Sorrento Valley Road, Suite 200

    iBio Financials

    Summary Financials

    Revenue (FY, 2024)
    $225.0K
    Net income (FY, 2024)
    ($24.9M)
    Cash (FY, 2024)
    $14.2M
    EBIT (FY, 2024)
    ($16.6M)
    Enterprise value
    $12.4M

    Footer menu